Navigation Links
Researchers identify role of gene in tumor development, growth and progression
Date:11/20/2009

RICHMOND, Va. (Nov. 20, 2009) Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Scientists hope the finding could lead to an effective therapy to target and inhibit the expression of this gene resulting in inhibition of cancer growth.

According to Paul B. Fisher, M.Ph., Ph.D., professor and chair of the Department of Human and Molecular Genetics, director of the VCU Institute of Molecular Medicine in the VCU School of Medicine, and program leader of Cancer Molecular Genetics at the Massey Cancer Center, the team has shown that astrocyte elevated gene-1, AEG-1, a cancer promoting gene, is involved in both oncogenic transformation, which is the conversion of a normal cell to a cancer cell, and angiogenesis, which is the formation of new blood cells. Oncogenic transformation and angiogenesis are critical for tumor development, growth and progression to metastasis.

In the study published online the week of Nov. 16 in the Early Edition of the journal Proceedings of the National Academy of Sciences, researchers employing a series of molecular studies reported that the elevated expression of AEG-1 is involved with turning normal cells into cancer cells.

According to Fisher, when AEG-1 was expressed in normal immortal rat embryo fibroblast cells it converted these cells into transformed cells that induced rapidly growing aggressive cancers when injected into animals. AEG-1 expressing cells displayed enhanced expression of genes regulating blood vessel formation, thereby contributing to tumorigenicity. The team has further defined the pathways in target cells that are activated by AEG-1 and mediate its oncogenic and angiogenic inducing properties.

"Our goal is to understand the functions of a novel gene AEG-1 that plays an essential role in tumor progression, with potential to develop effective therapeutic approaches for multiple cancers through targeted inhibition of this novel molecule or its downstream regulated processes," said Fisher, who is the first incumbent of the Thelma Newmeyer Corman Endowed Chair in Cancer Research with the VCU Massey Cancer Center.

"We believe it will pave the way for ameliorating the sufferings of scores of cancer patients by uncovering new and effective avenues for treatment," he said.

To expand the work on AEG-1, the VCU Department of Human and Molecular Genetics, Institute of Molecular Medicine and Massey Cancer Center recently received a National Cancer Institute grant totaling $1.6 million to study the AEG-1 gene in the context of malignant brain tumors such as glioblastoma multiforme, or GBM. According to Fisher, who is the primary investigator for the study, the work will extend the understanding of this gene and how it may serve as an oncogenic, or transforming gene.

"Cancer development and progression are multi-factor and multi-step processes that occur in a temporal manner. As mentioned above AEG-1 clearly has multiple roles in various steps of tumor progression, including tumor cell growth, insensitivity to growth-inhibitory signals, including chemotherapeutic agents, invasion, angiogenesis and metastasis," explained Fisher.

"In addition, AEG-1 has been known to have oncogenic roles in various cancers including glioma (CNS tumor), neuroblastoma, liver cancer, breast cancer, prostate cancer, lung cancer, and esophageal squamous cell carcinoma. These important correlations make this gene an intriguing molecule to study with potential to serve as a direct target for cancer therapy," he said.

The gene was discovered in 2002 in Fisher's laboratory while he was at the Columbia University College of Physicians and Surgeons in New York.


'/>"/>

Contact: Sathya Achia Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
Source:Eurekalert

Related medicine news :

1. On the trail of a vaccine for Lyme disease: Yale researchers target tick saliva
2. UCLA researchers create fly paper to capture circulating cancer cells
3. Researchers focus on helping dying patients take care of unfinished business
4. Mount Sinai researchers to test first gene therapy For Alzheimers patients
5. Wistar researchers show targeting normal cells in tumors slows growth
6. K-State researchers studying link between climate change and cattle nutritional stress
7. Cornell Researchers Identify a Weak Link in Cancer Cell Armor
8. Researchers notch a victory toward new kind of cancer drug
9. Emotions increase or decrease pain: researchers
10. Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits
11. U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... a contract to Quality Insights to help small practices in Delaware, New Jersey, ... Program, established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). ...
(Date:2/22/2017)... ... February 22, 2017 , ... Michael J. Hennessy ... platform connecting healthcare technology professionals and other key stakeholders with an array of ... starting on March 1, announced Michael J. Hennessy, Jr., president of MJH Associates. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued ... according to the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, ... such as the benefits of corn and grains, value of raw and organic diets, ...
(Date:2/22/2017)... ... February 22, 2017 , ... In today’s world, homeowners ... on the market, it is easy to start feeling frustrated and confused. To ... a complimentary security consultation. , Home Security Hardware Choices, There are innumerable choices ...
(Date:2/22/2017)... CALIFORNIA (PRWEB) , ... February 22, 2017 , ... ... the pipeline and the number of African American/Black students who want to become ... residents to pursue their careers as physicians in the Oakland/San Francisco Northern California, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Summary ... infarction partnering deals and agreements entered into by ... full report: http://www.reportlinker.com/p03605670-summary/view-report.html Description The ... understanding and access to partnering deals and agreements ... - Trends in partnering deals ...
(Date:2/22/2017)... Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced ... conference call and webcast at 8:30 a.m., Eastern time, on ... an update on Merrimack,s recent progress as well as a ... A press release detailing the information to be discussed on ... 1. Investors and the general public are invited to listen ...
(Date:2/22/2017)... YORK , Feb. 22, 2017 Summary ... neurone disease partnering deals and agreements entered into by ... report: http://www.reportlinker.com/p03605682-summary/view-report.html Description The Global Motor ... provides understanding and access to partnering deals and agreements ... - Trends in partnering deals - Top ...
Breaking Medicine Technology: